Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome

Hassan Abolhassani,Nils Landegren,Paul Bastard,Marie Materna,Mohammadreza Modaresi,Likun Du,Maribel Aranda-Guillén,Fabian Sardh,Fanglei Zuo,Peng Zhang,Harold Marcotte,Nico Marr,Taushif Khan,Manar Ata,Fatima Al-Ali,Remi Pescarmona,Alexandre Belot,Vivien Béziat,Qian Zhang,Jean-Laurent Casanova,Olle Kämpe,Shen-Ying Zhang,Lennart Hammarström,Qiang Pan-Hammarström

DOI: https://doi.org/10.1007/s10875-022-01215-7

IF: 8.542

2022-01-28

Journal of Clinical Immunology

Abstract:Abstract Background Inborn errors of immunity (IEI) and autoantibodies to type I interferons (IFNs) underlie critical COVID-19 pneumonia in at least 15% of the patients, while the causes of multisystem inflammatory syndrome in children (MIS-C) remain elusive. Objectives To detect causal genetic variants in very rare cases with concomitant critical COVID-19 pneumonia and MIS-C. Methods Whole exome sequencing was performed, and the impact of candidate gene variants was investigated. Plasma levels of cytokines, specific antibodies against the virus, and autoantibodies against type I IFNs were also measured. Results We report a 3-year-old child who died on day 56 of SARS-CoV-2 infection with an unusual clinical presentation, combining both critical COVID-19 pneumonia and MIS-C. We identified a large, homozygous loss-of-function deletion in IFNAR1 , underlying autosomal recessive IFNAR1 deficiency. Conclusions Our findings confirm that impaired type I IFN immunity can underlie critical COVID-19 pneumonia, while suggesting that it can also unexpectedly underlie concomitant MIS-C. Our report further raises the possibility that inherited or acquired dysregulation of type I IFN immunity might contribute to MIS-C in other patients.

immunology